BRTX - BioRestorative Therapies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2018
12/31/2017
12/31/2016
Total Revenue
127
111
81
36.355
Cost of Revenue
-
-
0
0.102
Gross Profit
-
-
81
36.253
Operating Expenses
Research Development
1,682
1,513
2,152
2,884
Selling General and Administrative
6,899
6,246
6,303
4,950
Total Operating Expenses
8,581
7,759
8,455
7,834
Operating Income or Loss
-8,454
-7,648
-8,374
-7,797
Interest Expense
1,323
932.187
468.107
221.608
Total Other Income/Expenses Net
-3,263
-1,648
17.002
-75.091
Income Before Tax
-16,668
-12,518
-9,445
-8,636
Income from Continuing Operations
-16,668
-12,518
-9,445
-8,636
Net Income
-16,668
-12,518
-9,445
-8,636
Net Income available to common shareholders
-16,668
-12,518
-9,445
-8,636
Basic EPS
-
-1.64
-1.74
-2.10
Diluted EPS
-
-1.64
-1.74
-2.10
Basic Average Shares
-
7,630
5,422
4,106
Diluted Average Shares
-
7,630
5,422
4,106
EBITDA
-
-11,345
-8,717
-8,156